Home
VCNX
VCNX News

Latest Vaccinex Inc. (VCNX) News on November 18, 2024

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

GlobeNewswire

11 days ago

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting

GlobeNewswire

13 days ago

Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain

GlobeNewswire

18 days ago

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024

GlobeNewswire

25 days ago

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024

MT Newswires

2 months ago

Top Midday Decliners

Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds

GlobeNewswire

2 months ago

Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds

Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership

GlobeNewswire

3 months ago

Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership

Vaccinex’s Phase Ib/II trial for Alzheimer’s treatment hits primary endpoint

Clinical Trials Arena

4 months ago

Vaccinex’s Phase Ib/II trial for Alzheimer’s treatment hits primary endpoint

Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease

GlobeNewswire

4 months ago

Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease

Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024

GlobeNewswire

4 months ago

Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

5 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

5 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

5 months ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

5 months ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

5 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

5 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

5 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

5 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease

GlobeNewswire

5 months ago

Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease

Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update

Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire

8 months ago

Vaccinex Reports 2023 Financial Results and Provides Corporate Update

Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

8 months ago

Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology

GlobeNewswire

9 months ago

Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology

Vaccinex, Inc. Announces Reverse Stock Split

GlobeNewswire

9 months ago

Vaccinex, Inc. Announces Reverse Stock Split

Steven Cohen's Point72 Asset Management Acquires New Stake in Vaccinex Inc

GuruFocus.com

9 months ago

Steven Cohen's Point72 Asset Management Acquires New Stake in Vaccinex Inc

Vaccinex Announces Pricing of $3.7 Million PIPE Financing

GlobeNewswire

9 months ago

Vaccinex Announces Pricing of $3.7 Million PIPE Financing

Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS

GlobeNewswire

10 months ago

Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS

Novagold Resources Inc (TSX:NG) Reports Fiscal Year 2023 Financial Results

GuruFocus.com

10 months ago

Novagold Resources Inc (TSX:NG) Reports Fiscal Year 2023 Financial Results

Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer

GlobeNewswire

10 months ago

Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

GlobeNewswire

10 months ago

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types

Business Wire

10 months ago

DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

10 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

PR Newswire

10 months ago

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

United-Guardian Appoints New Director

GlobeNewswire

10 months ago

United-Guardian Appoints New Director

Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation

GlobeNewswire

10 months ago

Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation

Ondas Holdings' American Robotics Engaged in AUVSI's Green UAS Program to Certify Compliance with Highest Levels of Cybersecurity and Accelerate Adoption of Optimus System by U.S. Federal and State Agencies

ACCESSWIRE

a year ago

Ondas Holdings' American Robotics Engaged in AUVSI's Green UAS Program to Certify Compliance with Highest Levels of Cybersecurity and Accelerate Adoption of Optimus System by U.S. Federal and State Agencies

Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024

PR Newswire

a year ago

Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

InvestorPlace

a year ago

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

These Stocks under $10 Are Poised To Explode

Insider Monkey

a year ago

These Stocks under $10 Are Poised To Explode

Intuitive Machines IM-1 Lunar Mission Launch Update

GlobeNewswire

a year ago

Intuitive Machines IM-1 Lunar Mission Launch Update

Edesa Biotech Reports Fiscal Year 2023 Results

ACCESSWIRE

a year ago

Edesa Biotech Reports Fiscal Year 2023 Results

3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023

InvestorPlace

a year ago

3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023

Stran & Company to Present at the Investor Summit on December 7th

GlobeNewswire

a year ago

Stran & Company to Present at the Investor Summit on December 7th

Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

GlobeNewswire

a year ago

Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

11 Cheapest Stocks With Biggest Upside

Insider Monkey

a year ago

11 Cheapest Stocks With Biggest Upside

Bright Green Announces Third Quarter 2023 Financial Update and Milestone Progress

GlobeNewswire

a year ago

Bright Green Announces Third Quarter 2023 Financial Update and Milestone Progress

SPI Energy Reports Positive Net Income from Continuing Operations in Q3 2023

ACCESSWIRE

a year ago

SPI Energy Reports Positive Net Income from Continuing Operations in Q3 2023

Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn’s and Colitis

GlobeNewswire

a year ago

Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn’s and Colitis

PAVmed Provides Business Update and Third Quarter Financial Results

PR Newswire

a year ago

PAVmed Provides Business Update and Third Quarter Financial Results

Dragonfly Energy Reports Third Quarter 2023 Financial and Operational Results

GlobeNewswire

a year ago

Dragonfly Energy Reports Third Quarter 2023 Financial and Operational Results

Is Kolibri Global Energy Inc.'s (TSE:KEI) Latest Stock Performance A Reflection Of Its Financial Health?

Simply Wall St.

a year ago

Is Kolibri Global Energy Inc.'s (TSE:KEI) Latest Stock Performance A Reflection Of Its Financial Health?

Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Independent Director of Eastern Picks Up 9.7% More Stock

Simply Wall St.

a year ago

Independent Director of Eastern Picks Up 9.7% More Stock

Grove Collaborative Sees Record 3Q Net Revenue Per Order, Raises Guidance

Exec Edge

a year ago

Grove Collaborative Sees Record 3Q Net Revenue Per Order, Raises Guidance

Great Elm Group, Inc. Schedules Fiscal 2024 First Quarter Conference Call and Webcast

GlobeNewswire

a year ago

Great Elm Group, Inc. Schedules Fiscal 2024 First Quarter Conference Call and Webcast

Stran & Company, Inc.'s (NASDAQ:SWAG) Low P/S No Reason For Excitement

Simply Wall St.

a year ago

Stran & Company, Inc.'s (NASDAQ:SWAG) Low P/S No Reason For Excitement

Share on Social Networks: